L

Lixa

10 employees

Lixa develops revolutionary, scalable solutions for antimicrobial resistance (AMR) and the US$5T per annum biofilm problem.

Basic info

Industry

biotechnology research

Sectors

Antimicrobial

Biotechnology

Human health

Silent pandemic

Biotech

Antifouling

AMR

Compatible to antimicrobials

Bacterial resistance

Antibiofilm

anti-infection

Equitable health

Animal health

Non-antibiotic

Life Science

Date founded

2021

FAQ